JP2011500781A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011500781A5 JP2011500781A5 JP2010530566A JP2010530566A JP2011500781A5 JP 2011500781 A5 JP2011500781 A5 JP 2011500781A5 JP 2010530566 A JP2010530566 A JP 2010530566A JP 2010530566 A JP2010530566 A JP 2010530566A JP 2011500781 A5 JP2011500781 A5 JP 2011500781A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- composition
- artemether
- triglycerides
- chain triglycerides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 25
- 229960000981 artemether Drugs 0.000 claims 12
- SXYIRMFQILZOAM-HVNFFKDJSA-N dihydroartemisinin methyl ether Chemical compound C1C[C@H]2[C@H](C)CC[C@H]3[C@@H](C)[C@@H](OC)O[C@H]4[C@]32OO[C@@]1(C)O4 SXYIRMFQILZOAM-HVNFFKDJSA-N 0.000 claims 12
- NLYNIRQVMRLPIQ-XQLAAWPRSA-N artemotil Chemical compound C1C[C@H]2[C@H](C)CC[C@H]3[C@@H](C)[C@@H](OCC)O[C@H]4[C@]32OO[C@@]1(C)O4 NLYNIRQVMRLPIQ-XQLAAWPRSA-N 0.000 claims 8
- 229960002970 artemotil Drugs 0.000 claims 8
- 239000000546 pharmaceutical excipient Substances 0.000 claims 8
- 229940057917 medium chain triglycerides Drugs 0.000 claims 7
- 150000003626 triacylglycerols Chemical class 0.000 claims 7
- 201000004792 malaria Diseases 0.000 claims 6
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 5
- 239000002253 acid Substances 0.000 claims 4
- DTMGIJFHGGCSLO-FIAQIACWSA-N ethyl (4z,7z,10z,13z,16z,19z)-docosa-4,7,10,13,16,19-hexaenoate;ethyl (5z,8z,11z,14z,17z)-icosa-5,8,11,14,17-pentaenoate Chemical class CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC.CCOC(=O)CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC DTMGIJFHGGCSLO-FIAQIACWSA-N 0.000 claims 4
- 229940013317 fish oils Drugs 0.000 claims 4
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 229940079593 drug Drugs 0.000 claims 3
- 230000002265 prevention Effects 0.000 claims 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 235000003441 saturated fatty acids Nutrition 0.000 claims 2
- 150000004671 saturated fatty acids Chemical class 0.000 claims 2
- 239000007921 spray Substances 0.000 claims 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims 1
- 235000019501 Lemon oil Nutrition 0.000 claims 1
- 235000019502 Orange oil Nutrition 0.000 claims 1
- 239000010634 clove oil Substances 0.000 claims 1
- 239000010501 lemon oil Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 claims 1
- 239000001683 mentha spicata herb oil Substances 0.000 claims 1
- 229940041616 menthol Drugs 0.000 claims 1
- 239000010502 orange oil Substances 0.000 claims 1
- 235000019477 peppermint oil Nutrition 0.000 claims 1
- 235000019721 spearmint oil Nutrition 0.000 claims 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 claims 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 claims 1
- 235000012141 vanillin Nutrition 0.000 claims 1
- 239000000341 volatile oil Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0720967.9 | 2007-10-25 | ||
| GBGB0720967.9A GB0720967D0 (en) | 2007-10-25 | 2007-10-25 | Anti-material pharmaceutical composition |
| GBGB0806510.4A GB0806510D0 (en) | 2007-10-25 | 2008-04-10 | Anti-malarial pharmaceutical composition |
| GB0806510.4 | 2008-04-10 | ||
| PCT/GB2008/050999 WO2009053758A1 (en) | 2007-10-25 | 2008-10-27 | Anti-malarial pharmaceutical composition |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013257016A Division JP2014088400A (ja) | 2007-10-25 | 2013-12-12 | 抗マラリア薬剤組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011500781A JP2011500781A (ja) | 2011-01-06 |
| JP2011500781A5 true JP2011500781A5 (enExample) | 2011-12-15 |
| JP5438018B2 JP5438018B2 (ja) | 2014-03-12 |
Family
ID=38829944
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010530566A Expired - Fee Related JP5438018B2 (ja) | 2007-10-25 | 2008-10-27 | 抗マラリア薬剤組成物 |
| JP2013257016A Pending JP2014088400A (ja) | 2007-10-25 | 2013-12-12 | 抗マラリア薬剤組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013257016A Pending JP2014088400A (ja) | 2007-10-25 | 2013-12-12 | 抗マラリア薬剤組成物 |
Country Status (25)
| Country | Link |
|---|---|
| US (5) | US20110015260A1 (enExample) |
| EP (3) | EP2749267A1 (enExample) |
| JP (2) | JP5438018B2 (enExample) |
| CN (2) | CN101835464B (enExample) |
| AP (2) | AP2920A (enExample) |
| AU (1) | AU2008315767B2 (enExample) |
| BR (2) | BR122013005952A2 (enExample) |
| CA (1) | CA2702506C (enExample) |
| CY (1) | CY1116759T1 (enExample) |
| DK (1) | DK2209464T3 (enExample) |
| EA (2) | EA026281B1 (enExample) |
| ES (2) | ES2494340T3 (enExample) |
| GB (3) | GB0720967D0 (enExample) |
| HR (1) | HRP20140773T1 (enExample) |
| MX (1) | MX2010004392A (enExample) |
| MY (2) | MY153119A (enExample) |
| NZ (1) | NZ584672A (enExample) |
| PE (1) | PE20091322A1 (enExample) |
| PH (2) | PH12010500880A1 (enExample) |
| PL (1) | PL2209464T3 (enExample) |
| PT (1) | PT2209464E (enExample) |
| RS (1) | RS53507B1 (enExample) |
| SI (1) | SI2209464T1 (enExample) |
| WO (1) | WO2009053758A1 (enExample) |
| ZA (1) | ZA201002607B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140256761A1 (en) * | 2009-04-22 | 2014-09-11 | Robert Lewis Steele | Enhanced artemisinin-based combination therapy for treating parasitic mediated disease |
| GB2469792A (en) * | 2009-04-23 | 2010-11-03 | Calvin John Ross | Oil-based pharmaceutical formulation for sublingual delivery |
| WO2010122355A1 (en) * | 2009-04-23 | 2010-10-28 | Londonpharma Ltd. | Sublingual pharmaceutical composition comprising a neutral oil |
| GB2469791B (en) * | 2009-04-23 | 2011-12-14 | Londonpharma Ltd | Transmucosal formulation of compounds providing dihydroartemesinin for use in the treatment of neoplastic disease |
| US8290525B2 (en) | 2010-01-15 | 2012-10-16 | Comcast Cable Communications, Llc | Text alternative to established voice call session |
| US8481757B2 (en) * | 2010-02-04 | 2013-07-09 | Georgua Tech Research Corporation | Compounds and compositions useful in the treatment of malaria |
| US20140256762A1 (en) * | 2012-07-06 | 2014-09-11 | Robert Lewis Steele | Artemisinin-based combination therapy for treating viral mediated disease |
| TWI733649B (zh) * | 2014-03-07 | 2021-07-21 | 巴哈馬商克利普頓集團公司 | 用於治療寄生蟲介導疾病之強化的基於青蒿素組合療法 |
| GB201414918D0 (en) * | 2014-08-21 | 2014-10-08 | Corbitt Terence Simon | Formulations for transmucosal delivery |
| GB201414919D0 (en) * | 2014-08-21 | 2014-10-08 | Corbitt Terence Simon | Formulations for transmucosal delivery |
| WO2016083827A1 (en) * | 2014-11-27 | 2016-06-02 | Cipla Limited | Pharmaceutical composition comprising an artemisinin derivative for nasal or pulmonary delivery |
| US20220280734A1 (en) * | 2021-03-07 | 2022-09-08 | Sultan A. M. Daham | Intaking an antiviral by inhalation or spraying for respiratory tract infection |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT84439B (pt) * | 1986-03-10 | 1989-10-04 | Burghart Kurt | Processo de preparacao de composicoes farmaceuticas a base de nifedipina |
| US5057501A (en) * | 1990-03-13 | 1991-10-15 | Dermatologic Research Corporation | Methods for treatment of papulosquamous and eczematous diseases |
| US20020099067A1 (en) * | 1993-07-08 | 2002-07-25 | Ulrich Posanski | Pharmaceutical compositions for sparingly soluble therapeutic agents |
| US5578637A (en) * | 1995-05-03 | 1996-11-26 | University Of Washington | Methods of inhibition or killing cancer cells using an endoperoxide |
| US20030082107A1 (en) * | 1997-10-01 | 2003-05-01 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer |
| US20030095926A1 (en) * | 1997-10-01 | 2003-05-22 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract |
| US20050281752A1 (en) * | 1997-10-01 | 2005-12-22 | Dugger Harry A Iii | Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
| CH692321A5 (de) | 1997-11-03 | 2002-05-15 | Mepha Ag | Pharmazeutisch wirksame Zusammensetzung, welche eine gegen Malariaparasiten wirksame Substanz enthält. |
| RU2129809C1 (ru) * | 1998-04-24 | 1999-05-10 | Захарчук Анатолий Васильевич | Способ получения пищевого продукта в капсулах |
| CN1084333C (zh) * | 1998-06-17 | 2002-05-08 | 中国科学院上海药物研究所 | 新的青蒿素化合物,其制备方法以及含有它们的药物组合物 |
| SK542001A3 (en) * | 1998-07-14 | 2001-08-06 | Bayer Ag | Antiparasitic artemisinin derivatives (endoperoxides) |
| US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| ES2153786B1 (es) * | 1999-06-10 | 2001-10-16 | S A L V A T Lab Sa | Composicion farmaceutica liquida para la administracion oral de principios activos amargos y susceptibles de hidrolisis. |
| FR2796276B1 (fr) * | 1999-07-15 | 2003-05-16 | Oreal | Composition sous forme solide comprenant une huile et un compose gelifiant particulier, procede de traitement cosmetique et utilisation dudit compose |
| US6617356B2 (en) * | 2000-01-03 | 2003-09-09 | Naturally Scientific Inc | Gel system for oral and topical administration of water insoluble and/or water intolerant drugs and supplements |
| JP3752127B2 (ja) * | 2000-03-21 | 2006-03-08 | 花王株式会社 | 油脂組成物 |
| JP2003534356A (ja) * | 2000-06-02 | 2003-11-18 | フォーブス メディ−テック インコーポレーテッド | 短鎖、中鎖及び長鎖トリグリセリドから成る油組成物及び体重増加を減少させるためのその使用。 |
| WO2002032905A1 (en) * | 2000-10-20 | 2002-04-25 | Ajinomoto Co.,Inc. | Medicinal compositions, dose and method for treating malaria |
| US6951846B2 (en) * | 2002-03-07 | 2005-10-04 | The United States Of America As Represented By The Secretary Of The Army | Artemisinins with improved stability and bioavailability for therapeutic drug development and application |
| SI1575569T1 (sl) * | 2002-12-13 | 2010-12-31 | Durect Corp | Oralni sistem dostave zdravila, ki obsega visokoviskozne tekoče nosilne materiale |
| JP2004307428A (ja) * | 2003-04-10 | 2004-11-04 | Porien Project Kk | 原虫感染症予防治療薬 |
| US20050042281A1 (en) * | 2003-08-21 | 2005-02-24 | Singh Nikhilesh N. | Compositions for delivering therapeutic agents across the oral mucosa |
| CA2578709C (en) * | 2004-06-17 | 2010-06-15 | Virun, Inc. | Compositions comprising a mucoadhesive protein and an active principle for mucosal delivery of said agents |
| CN1650854A (zh) * | 2004-12-08 | 2005-08-10 | 广州中生生物技术有限公司 | 一种含有蒿甲醚（或蒿乙醚或蒿琥酯）微乳剂的制备工艺 |
| US20060233895A1 (en) * | 2005-04-15 | 2006-10-19 | Brown Paul R | Herbal remedy for treating Lyme disease |
| US20060263427A1 (en) * | 2005-05-03 | 2006-11-23 | Roberts Richard H | Quinine formulations |
| EP1933809B1 (en) * | 2005-10-11 | 2012-02-08 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Compositions for nasal delivery |
| MX374396B (es) * | 2006-01-25 | 2025-03-06 | Insys Therapeutics Inc | Rocio de fentanilo sublingual. |
| CN101310720A (zh) * | 2007-05-22 | 2008-11-26 | 天津丹溪国药研究所 | 一种治疗疟疾的蒿甲醚滴丸剂的制备方法 |
| CN101317839A (zh) * | 2007-06-05 | 2008-12-10 | 天津丹溪国药研究所 | 一种治疗疟疾的复方蒿甲醚滴丸剂的制备方法 |
| WO2010122355A1 (en) * | 2009-04-23 | 2010-10-28 | Londonpharma Ltd. | Sublingual pharmaceutical composition comprising a neutral oil |
| MX2011010961A (es) * | 2009-04-23 | 2012-04-20 | Londonpharma Ltd | Formula en aspersion sublingual que comprende dihidroartemesinina. |
| GB2481619B (en) * | 2010-06-30 | 2012-06-20 | Londonpharma Ltd | Formulations and delivery devices for the sublingual administration of opioids |
-
2007
- 2007-10-25 GB GBGB0720967.9A patent/GB0720967D0/en not_active Ceased
-
2008
- 2008-04-10 GB GBGB0806510.4A patent/GB0806510D0/en not_active Ceased
- 2008-10-27 ES ES08806806.9T patent/ES2494340T3/es active Active
- 2008-10-27 EP EP14161340.6A patent/EP2749267A1/en not_active Withdrawn
- 2008-10-27 WO PCT/GB2008/050999 patent/WO2009053758A1/en not_active Ceased
- 2008-10-27 RS RSP20140453 patent/RS53507B1/sr unknown
- 2008-10-27 AP AP2010005231A patent/AP2920A/xx active
- 2008-10-27 GB GB0819559A patent/GB2454567B/en not_active Expired - Fee Related
- 2008-10-27 CN CN2008801133380A patent/CN101835464B/zh not_active Expired - Fee Related
- 2008-10-27 AU AU2008315767A patent/AU2008315767B2/en not_active Ceased
- 2008-10-27 MX MX2010004392A patent/MX2010004392A/es active IP Right Grant
- 2008-10-27 BR BRBR122013005952-0A patent/BR122013005952A2/pt not_active Application Discontinuation
- 2008-10-27 PT PT88068069T patent/PT2209464E/pt unknown
- 2008-10-27 CA CA2702506A patent/CA2702506C/en not_active Expired - Fee Related
- 2008-10-27 SI SI200831270T patent/SI2209464T1/sl unknown
- 2008-10-27 US US12/739,258 patent/US20110015260A1/en not_active Abandoned
- 2008-10-27 HR HRP20140773AT patent/HRP20140773T1/hr unknown
- 2008-10-27 EP EP08806806.9A patent/EP2209464B1/en active Active
- 2008-10-27 EA EA201300151A patent/EA026281B1/ru not_active IP Right Cessation
- 2008-10-27 ES ES13176933.3T patent/ES2540727T3/es active Active
- 2008-10-27 EA EA201000497A patent/EA017804B1/ru not_active IP Right Cessation
- 2008-10-27 PH PH12010500880A patent/PH12010500880A1/en unknown
- 2008-10-27 JP JP2010530566A patent/JP5438018B2/ja not_active Expired - Fee Related
- 2008-10-27 CN CN201310093313.1A patent/CN103622950B/zh not_active Expired - Fee Related
- 2008-10-27 NZ NZ584672A patent/NZ584672A/en not_active IP Right Cessation
- 2008-10-27 DK DK08806806.9T patent/DK2209464T3/da active
- 2008-10-27 AP AP2013006997A patent/AP3542A/xx active
- 2008-10-27 MY MYPI20101793 patent/MY153119A/en unknown
- 2008-10-27 PL PL08806806T patent/PL2209464T3/pl unknown
- 2008-10-27 EP EP13176933.3A patent/EP2653153B1/en not_active Not-in-force
- 2008-10-27 MY MYPI2013002816A patent/MY161745A/en unknown
- 2008-10-27 BR BRPI0817833A patent/BRPI0817833A8/pt not_active Application Discontinuation
-
2009
- 2009-01-21 PE PE2009000071A patent/PE20091322A1/es active IP Right Grant
-
2010
- 2010-04-14 ZA ZA2010/02607A patent/ZA201002607B/en unknown
-
2013
- 2013-07-24 PH PH12013501567A patent/PH12013501567A1/en unknown
- 2013-07-26 US US13/952,262 patent/US20140179772A1/en not_active Abandoned
- 2013-12-12 JP JP2013257016A patent/JP2014088400A/ja active Pending
-
2014
- 2014-08-26 CY CY20141100682T patent/CY1116759T1/el unknown
-
2015
- 2015-07-24 US US14/808,707 patent/US20160038404A1/en not_active Abandoned
-
2017
- 2017-11-20 US US15/818,548 patent/US20180071207A1/en not_active Abandoned
-
2019
- 2019-06-03 US US16/430,040 patent/US20190290576A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011500781A5 (enExample) | ||
| JP5438018B2 (ja) | 抗マラリア薬剤組成物 | |
| JP2022180461A5 (enExample) | ||
| AR065579A1 (es) | Mejoras en composiciones medicinales o relativas a las mismas | |
| JP2009102342A5 (enExample) | ||
| HRP20140592T1 (hr) | Poboljšani medicinski pripravci koji sadrže buprenorfin i naltrekson | |
| JP2016505050A5 (enExample) | ||
| RU2501550C2 (ru) | Сублингвальная спреевая композиция, содержащая дигидроартемизинин | |
| JP2012524772A5 (enExample) | ||
| CA3151070A1 (en) | Orally dissolving mucoadhesive films utilizing menthol and l-arginine to enhance the bioavailability of cannabinoids | |
| AU2013201643B2 (en) | Anti-malarial pharmaceutical composition | |
| RU2023125283A (ru) | Фармацевтические композиции, содержащие флурбипрофен | |
| WO2010122275A1 (en) | Pharmaceutical preparation | |
| HK1164140B (en) | Sublingual spray formulation comprising dihydroartemesinin | |
| GB2469791A (en) | Lipophilic compositions comprising an artemisinin derivative and their therapeutic uses | |
| GB2482431A (en) | Transmucosal formulation of compounds providing dihydroartemesinin for use in the treatment of a fluke infestation | |
| HK1190645B (en) | Anti-malarial pharmaceutical composition |